JAKARTA (Yosefardi) – Largest pharmaceutical distributor in Indonesia, PT Enseval Putera Megatrading Tbk (EPMT) posted net profit of Rp219.2 billion in first quarter of this year, flat compared to Rp218 billion in the same period of last year.
Net sales grew by 13% to Rp8.22 trillion from previous Rp7.27 trillion. Cost of goods sold increased 12.5% to Rp7.3 trillion from earlier Rp6.49 trillion.
Its assets totaled Rp5.91 trillion while liability amounted Rp2.65 trillion. It has cash and cash equivalent of Rp193 billion.